Literature DB >> 5451357

Effects of iron, riboflavin and iodide deficiencies on hepatic drug-metabolizing enzyme systems.

C S Catz, M R Juchau, S J Yaffe.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5451357

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  5 in total

Review 1.  Drug metabolism and pharmacokinetics in malutrition.

Authors:  K Krishnaswamy
Journal:  Clin Pharmacokinet       Date:  1978 May-Jun       Impact factor: 6.447

2.  Metabolism of sulphadiazine in malnutrition.

Authors:  R Arunkumar Shastri; K Krishnaswamy
Journal:  Br J Clin Pharmacol       Date:  1979-01       Impact factor: 4.335

3.  Hepatic drug hydroxylation and lipid peroxidation in riboflavin-deficient rats.

Authors:  J M Patel; N R Galdhar; S S Pawar
Journal:  Biochem J       Date:  1974-06       Impact factor: 3.857

4.  Effect of erythropoietin on hepatic cytochrome P450 expression and function in an adenine-fed rat model of chronic kidney disease.

Authors:  D A Feere; T J Velenosi; B L Urquhart
Journal:  Br J Pharmacol       Date:  2014-11-24       Impact factor: 8.739

Review 5.  Hepatic heme metabolism and its control.

Authors:  H L Bonkowsky; P R Sinclair; J F Sinclair
Journal:  Yale J Biol Med       Date:  1979 Jan-Feb
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.